Rybelsus 14 mg
  1. Home
  2. Rybelsus
  3. Rybelsus 14 mg

Rybelsus 14 mg

Rybelsus 14 mg is a prescription oral GLP-1 receptor agonist containing semaglutide for improving glycemic control in adults with type 2 diabetes when used alongside diet and exercise. It provides convenient once-daily oral administration without the need for injections. The 14 mg strength is commonly used as a maintenance dose according to the prescribed treatment plan.

BUY NOW

Category

Rybelsus 14 mg contains semaglutide, a GLP-1 receptor agonist that helps improve blood glucose control by stimulating glucose-dependent insulin secretion, suppressing glucagon release, slowing gastric emptying, and promoting satiety. The once-daily oral formulation offers a non-injectable alternative for eligible patients requiring GLP-1 therapy, with the 14 mg strength commonly prescribed for ongoing maintenance after dose escalation. Manufactured under stringent pharmaceutical quality standards, the tablets are supplied in blister packs for convenient daily administration and storage. Rybelsus should be taken only under the supervision of a qualified healthcare professional according to the prescribed treatment plan.

Technical Specification

Specification Details
Product Name Rybelsus 14 mg
Active Ingredient Semaglutide
Strength 14 mg
Dosage Form Oral Tablet
Route of Administration Oral
Storage Store below 30°C in a dry place

Product Also Known As

Rybelsus 14 mg, Semaglutide 14 mg, Rybelsus Oral Tablet, Oral Semaglutide 14 mg, GLP-1 Diabetes Tablet, Once-Daily Semaglutide Tablet, Oral Antidiabetic Tablet